Author:
Bozovičar Krištof,Jenko Bizjan Barbara,Meden Anže,Kovač Jernej,Bratkovič Tomaž
Abstract
AbstractAffinity chromatography is the linchpin of antibody downstream processing and typically relies on bacterial immunoglobulin (Ig)-binding proteins, epitomized by staphylococcal protein A-based ligands. However, such affinity ligands are fairly costly and suffer from chemical instability, leading to ligand denaturation and leaching from chromatographic support. Innovations in this area are aimed at developing robust and highly selective antibody ligands capable of withstanding harsh column sanitization conditions. We report the development and first-stage characterization of a selective short linear peptide ligand of the IgG Fc region capable of capturing all four IgG subclasses. The ligand was discovered through in vitro directed evolution. A focused phage-display library based on a previously identified peptide lead was subjected to a single-round screen against a pool of human IgG. The hits were identified with next-generation sequencing and ranked according to the enrichment ratio relative to their frequency in the pre-screened library. The top enriched peptide GSYWYNVWF displaying highest affinity for IgG was coupled to bromohydrin-activated agarose beads via a branched linker. The resulting affinity matrix was characterized with a dynamic binding capacity of approx. 43 mg/mL, on par with commercially employed protein A-based resin.
Funder
University of Ljubljana Innovation Fund
Javna Agencija za Raziskovalno Dejavnost RS
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Saeed, A. F. U. H., Wang, R., Ling, S. & Wang, S. Antibody engineering for pursuing a healthier future. Front. Microbiol. 8, 495 (2017).
2. Flanagan, M. L., Arias, R. S., Hu, P., Khawli, L. A. & Epstein, A. L. Soluble Fc fusion proteins for biomedical research. Methods Mol. Biol. 378, 33–52 (2007).
3. Farid, S. S. Process economics of industrial monoclonal antibody manufacture. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 848, 8–18 (2007).
4. Bolton, G. R. & Mehta, K. K. The role of more than 40 years of improvement in protein A chromatography in the growth of the therapeutic antibody industry. Biotechnol. Prog. 32, 1193–1202 (2016).
5. Low, D., O’Leary, R. & Pujar, N. S. Future of antibody purification. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 848, 48–63 (2007).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献